Division of Internal Medicine for the Aged, Geneva University Hospitals, Thônex, Switzerland
Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
BMJ Open. 2022 May 6;12(5):e055869. doi: 10.1136/bmjopen-2021-055869.
Pneumonia is a leading cause of mortality and a common indication for antibiotic in elderly patients. However, its diagnosis is often inaccurate. We aim to compare the diagnostic accuracy, the clinical and cost outcomes and the use of antibiotics associated with three imaging strategies in patients >65 years old with suspected pneumonia in the emergency room (ER): chest X-ray (CXR, standard of care), low-dose CT scan (LDCT) or lung ultrasonography (LUS).
This is a multicentre randomised superiority clinical trial with three parallel arms. Patients will be allocated in the ER to a diagnostic strategy based on either CXR, LDCT or LUS. All three imaging modalities will be performed but the results of two of them will be masked during 5 days to the patients, the physicians in charge of the patients and the investigators according to random allocation. The primary objective is to compare the accuracy of LDCT versus CXR-based strategies. As secondary objectives, antibiotics prescription, clinical and cost outcomes will be compared, and the same analyses repeated to compare the LUS and CXR strategies. The reference diagnosis will be established a posteriori by a panel of experts. Based on a previous study, we expect an improvement of 16% of the accuracy of pneumonia diagnosis using LDCT instead of CXR. Under this assumption, and accounting for 10% of drop-out, the enrolment of 495 patients is needed to prove the superiority of LDCT over CRX (alpha error=0.05, beta error=0.10).
Ethical approval: CER Geneva 2019-01288.
NCT04978116.
肺炎是导致老年人死亡的主要原因之一,也是老年人使用抗生素的常见指征。然而,其诊断往往不够准确。我们旨在比较三种影像学策略(胸部 X 线(CXR,标准护理)、低剂量 CT 扫描(LDCT)或肺部超声(LUS))在急诊科(ER)疑似肺炎的>65 岁患者中的诊断准确性、临床和成本结果以及抗生素的使用。
这是一项具有三个平行臂的多中心随机优势临床试验。患者将在 ER 中根据 CXR、LDCT 或 LUS 分配到诊断策略中。将对所有三种成像方式进行检查,但在 5 天内根据随机分配将两种结果(CXR 和 LDCT)对患者、负责患者的医生和研究人员进行屏蔽。主要目标是比较 LDCT 与基于 CXR 的策略的准确性。作为次要目标,将比较抗生素的处方、临床和成本结果,并重复相同的分析以比较 LUS 和 CXR 策略。参考诊断将由专家组建立。根据一项先前的研究,我们预计使用 LDCT 而不是 CXR 可将肺炎诊断的准确性提高 16%。根据这一假设,并考虑到 10%的脱落率,需要招募 495 名患者以证明 LDCT 优于 CRX(alpha 误差=0.05,beta 误差=0.10)。
伦理批准:日内瓦 CER 2019-01288。
NCT04978116。